Search clinical trials for: 2.50mg bevacizumab

Total 3587 results

Hunan Kelun Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions

Bioequivalence Study
Fudan University

Not yet recruiting

Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy

Metastatic Liver Cancer

China
University Medical Center Groningen

Completed

VEGF Imaging in Renal Cell Carcinoma (Renimage)

Renal Cell Carcinoma

Netherlands
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

Choroidal Neovascularization

Brazil
South Eastern European Research Oncology Group
Roche Pharma AG

Unknown

Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer

Breast Cancer | Metastasis

Croatia
Nanfang Hospital of Southern Medical University

Recruiting

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer

Colorectal Cancer Stage IV

China
ARCAGY/ GINECO GROUP

Active, not recruiting

PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer . (NEOPEMBROV)

Ovarian Cancer Stage IV

France
Sun Yat-sen University
The First Hospital of Nanchang

Not yet recruiting

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors

Advanced Solid Tumors | Metastatic Solid Tumors

China
Fudan University

Recruiting

Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer

Colorectal Cancer

China
Asociación para Evitar la Ceguera en México

Withdrawn

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Diabetic Macular Edema | Diabetes Mellitus Type 2

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

Choroidal Neovascularization | Diabetic Proliferative Retinopathy | Vascular Vein Oclussion
University Medical Center Groningen
Dutch Cancer Society

Enrolling by invitation

Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW (TARGET-beva)

Surgery | Thyroid Carcinoma

Netherlands
Amsterdam UMC, location VUmc
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Noordwest...

Unknown

Angiogenic Factor Expression During Fractionated Irradiation

Primary Esophageal Carcinoma

Netherlands
West Virginia University

Withdrawn

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

Central Nervous System Tumors

United States
Hoffmann-La Roche

Completed

Observational Study of Bevacizumab [Avastin] in Patients With Metastatic Colorectal Cancer (AVASTART)

Colorectal Cancer

Belgium
University of Pittsburgh
Genentech, Inc.

Withdrawn

Pilot Study for Locally Advanced Head and Neck Cancer

Head and Neck Neoplasms

United States
Walter Reed Army Medical Center
Massachusetts Eye and Ear Infirmary

Completed

Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization

Corneal Neovascularization

United States
Genentech, Inc.

Completed

An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Cancer
Asan Medical Center

Completed

Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC) (SAFE)

Metastatic Colorectal Cancer

Korea, Republic of
Peking University People's Hospital

Completed

Bevacizumab for Neovascular Age-related Macular Degeneration

Exudative Age-related Macular Degeneration

China
University of Sao Paulo

Unknown

Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage (ABeVi)

Hemorrhage | Recurrent

Brazil
Medical University of Vienna

Terminated

Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma

Austria
Narayana Nethralaya

Unknown

Intravitreal Bevacizumab for Retinal Disorders

Proliferative Diabetic Retinopathy | Wet AMD | Macular Oedema

India
Hyundai Pharmaceutical Co., LTD.

Completed

Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)

Healthy Male
University Medical Center Groningen
Novartis

Completed

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma (Everolimage)

Metastatic Renal Cell Carcinoma

Netherlands
University Medical Center Groningen
VHL Alliance

Completed

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease (VHLimage)

Renal Cell Carcinoma | Von Hippel-Lindau Disease | Pheochromocytoma | Pancreatic Neuroendocrine Tumor | Hemangioblastoma

Netherlands
Pfizer

Completed

A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)

Healthy

United States
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; North Central...

Active, not recruiting

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Breast Adenocarcinoma

United States, Peru, South Africa
Chong Kun Dang Pharmaceutical

Completed

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus (DISCOVERY)

Type2 Diabetes

Korea, Republic of
Asociación para Evitar la Ceguera en México

Withdrawn

Unilateral Bevacizumab for Bilateral Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Northwestern University
National Cancer Institute (NCI)

Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors

United States
Stanford University
National Cancer Institute (NCI)

Completed

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States
European Organisation for Research and Treatment...

Completed

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Netherlands, Sweden, United Kingdom
Centre Hospitalier Universitaire de Nice

Terminated

A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts

Myelodysplastic Syndromes

France
Instituto de Olhos de Goiania

Completed

Intraocular Bevacizumab (Avastin) for Rubeosis Iridis

Glaucoma | Rubeosis Iridis
Instituto de Olhos de Goiania

Completed

Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration

Age Related Macular Degeneration
British Columbia Cancer Agency

Completed

Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial

Advanced Colorectal Cancer

Canada
University of Sao Paulo

Unknown

Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage

Vitreous Hemorrhage Secondary to PDR

Brazil
Capital Medical University

Unknown

Bleb Vascularity Change After Subconjunctival Injection Bevacizumab

Bleb Vascularity | Conjunctival Scarring

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

Poorly Differentiated Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma | Unresectable Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 | Stage IVA Thyroid Gland...

United States
Yonsei University

Unknown

Comparison of Propofol 1mg/kg and Propofol 0.5mg/kg for Prevention of Emergence Agitation in Children Undergoing Strabismus Surgery During Sevoflurane Anesthesia

Strabismus

Korea, Republic of
Nanfang Hospital of Southern Medical University

Recruiting

The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

Colorectal Neoplasms Malignant

China
National Taiwan University Hospital

Completed

Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy (VL)

Proliferative Diabetic Retinopathy

Taiwan
Suzhou Kintor Pharmaceutical Inc,

Completed

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

Alopecia | Male Pattern Hair Loss

United States
Hull University Teaching Hospitals NHS Trust

Completed

Azithromycin a Treatment for Pulmonary Sarcoidosis (CAPS)

Sarcoidosis, Pulmonary

United Kingdom
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM) (DREAM)

Colorectal Cancer

France, Austria, Canada
Fudan University

Recruiting

Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | Microsatellite Stable Colorectal Carcinoma | RAS Mutation | Cadonilimab

China
Sun Yat-sen University

Recruiting

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Hepatocellular Carcinoma

China

Search clinical trials for: 2.50mg bevacizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations